The Company


The Company


Avergen Pharmaceutical GmbH (APG) creates long-term value through internal and collaborative innovative drug discovery programs based on novel drug targets. APG is dedicated on its core competences in neurodegenerative diseases indications. APG is focused on drug development until phase II clinical studies.The location of the company in Munich enables the access to experienced experts in the field of drug discovery and development, as well as business development and commercialization.








Avergen Pharmaceuticals GmbH


Handelsregister beim Amtsgericht München, Nr. HRB 217756


Vertreten wird die Avergen Pharmaceuticals GmbH durch seinen Geschäftsführer:

Dr. med. Murat Yildiz


Umsatzsteueridentifikationsnummer: DE300119217


Zuständige Aufsichtsbehörde: Regierung von Oberbayern




Am Klopferspitz 19

82152 Martinsried